TrialDiabetes technology & therapeutics2018

Effects of Dapagliflozin on 24-Hour Glycemic Control in Patients with Type 2 Diabetes: A Randomized Controlled Trial.

Robert R Henry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.